Screener
Opko Health OPK Pharmaceutical — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) / Revenue from services: / Pharmaceutical | For the three months ended June 30, 2026 / — | For the three months ended June 30, 2025 / — | For the six months ended June 30, 2026 / — | For the six months ended June 30, 2025 / — |
|---|---|---|---|---|
| Corporate | — | — | — | — |
| $83,563 | $107,405 | $162,003 | $214,737 | |
| Gross margin: | ||||
| Pharmaceutical | $63,930 | $30,684 | $93,643 | $54,978 |
| Diagnostics | 16,087 | 18,718 | 32,131 | 37,044 |
| Corporate | — | — | — | — |
| $80,017 | $49,402 | $125,774 | $92,022 | |
| Selling, general and administrative: |
Item 1. Financial Statements
FAQ
- What is Opko Health's pharmaceutical — gross profit?
- Opko Health (OPK) reported pharmaceutical — gross profit of $63.93M in Q2 2026.
- How has Opko Health's pharmaceutical — gross profit changed year-over-year?
- Opko Health's pharmaceutical — gross profit increased by 108.3% year-over-year, from $30.68M to $63.93M.
- What is the long-term trend for Opko Health's pharmaceutical — gross profit?
- Over 2 years (2023 to 2025), Opko Health's pharmaceutical — gross profit has grown at a -24.2% compound annual growth rate (CAGR), from $248.68M to $143.02M.
- What does pharmaceutical — gross profit mean?
- The residual profit earned by the pharmaceutical segment after deducting the direct costs of production from total segment revenue. It measures the core profitability and production efficiency of the pharmaceutical business before operating expenses.
Ask your AI about Opko Health's pharmaceutical — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude